Biostar stock: buy or sell?

BSPM stock price: $0.08 14.29% At close on February 21st, 2020

Updated on:
February 21st, 2020

0

On February/13 BSPM collapsed a dreadful -114.29%. Biostar Pharmaceuticals shares climbed 14.29% to $0.08 today.

Biostar Pharmaceuticals, Inc. develops, manufactures, and markets over-the-counter (OTC) and prescription pharmaceutical products for various diseases and conditions in the People's Republic of China.

Should I buy Biostar stock?

You can't be a successful trader if you don't follow a methodolgy or system that assist you in choosing companies and the correct market timing. That's why is so important to define your own trading plan that matches with your character as inversor. There are thousands of trading strategies for you to choose, but at Stocks2.com we prefer those that are simple but successful.

None of our preferred buy setups matches with Biostar Pharmaceuticals stock situation right now, hence this is not a suitable entry point.

Buy setupElegible
New all-time highNo
New 52 week highNo
Price crossing up 200d MANo
100d MA crossing up 200d MANo
This doesn't mean BSPM will fall in coming sessions, or it will not rise higher. Simply, it doesn't match our recommended trading systems.

Is Biostar stock a buy?

Everyday, hundreds of stock ratings are published by financial analysts to indicate a particular stock's attractiveness. Unfortunately, we couldn't detect any rating for BSPM stock for the last month.

Biostar stock analysis

Daily outlook

Shares of Biostar Pharmaceuticals closed today at $0.08 and climbed an exceptional 14.29%.

Shares of Biostar climbed an exceptional 14.29% and closed at $0.08.

BSPM stock chart (daily)

Weekly outlook

After sliding a bloodcurdling -42.86% in a week last week, Biostar Pharmaceuticals closed this week at $0.08 and climbed a dazzling 14.29%.

Since early February, when BSPM stock price broke down the 20-weeks moving avarage line, it slid $-0.09 per share (-52.94%).

BSPM stock chart (weekly)

Biostar stock price history

Biostar stock went public on December 29th, 2009 with a price of $81.901. Since then, BSPM stock declined a -99.90%, with a yearly average of -10.00%.

1: Adjusted price after possible price splits or reverse-splits.

Biostar stock historical price chart

BSPM stock reached 52-week highs at $4.07, and all-time highs 2010-04-23 with a price of 115.71.

Biostar stock price target

How much a stock will be priced tomorrow or next week is quite unpredictable However, banks and other financial institutions analysts, with the help of lots of data and algorithms do their best to predict the stock prices movement. We do not recommend to follow these stock price predictions without a critical thinking from your side, as their accuracy is usually low. For the last month we have not detected any price forecast for Biostar Pharmaceuticals stock by any trusted analyst.

Financials and fundamental analysis

Earnings date and Earnings per Share

, when Biostar Pharmaceuticals posted its last earnings report, it . As soon as we get its posted EPS from the earnings report, we will update this report.
BSPM earnings date and EPS evolution
QuarterReporting dateEstimated EPSActual EPSSurprise
2016-Q3-n/a-0.71n/a
2016-Q4-n/a1.33n/a
2017-Q1-n/a-0.38n/a
2017-Q22017-11-15n/a-0.5n/a
2017-Q32017-11-20n/a-0.05n/a
2017-Q42018-04-12n/an/an/a
2018-Q12018-07-06n/an/an/a

Annual financial results

Compared to 2015, last anual revenues report draw a dreadful drop down of -91.21% to $2.38 M USD. When comparing 2016 vs 2015, in the same way, profit margin (that is, the net income divided by revenues) collapsed a -146.41% to -238.98%.

BSPM annual Sales and Income evolution
YearSalesYoYIncome/(margin)YoY
2012$49 M-$-20.00 M-40.6%-
2013$53 M6.91%$0.81 M1.5%-104.05%
2014$61 M16.48%$4.85 M7.9%499.25%
2015$27 M-55.83%$-25.11 M-92.6%-617.98%
2016$2.38 M-91.21%$-5.70 M-239.0%-77.31%

Quarterly financial results

Reported quarter earnings marked M with a profit margin of . Profit margin remained constant a 0.00% compared to previous quarter when profit margin was nan%. When comparing revenues to same quarter last year, Biostar Pharmaceuticals sales marked a neutral movement and stayed stable a nan%. Looking back to recent quarterly results, Biostar Pharmaceuticals posted 6 negative quarters in a row.
BSPM quarterly Sales and Income evolution
QuarterSales1QoQ2Income1/(margin)QoQ2
2016-Q3$0.64 M-$-1.56 M-241.9%-
2016-Q4$0.32 M-50.72%$3.39 M1066.1%-317.18%

Biostar ownership

When you are planning to buy shares of a stock, it's worth to overview its ownership structure.

Management staff in all public traded companies that hold equity is required to report every transaction to the SEC. For Biostar, 16.19% of all outstanding shares are owned by its staff.

In case of Biostar Pharmaceuticals stock, 0.00% of its shares are held by institutions (mutual funds, pension funds, big banks and other large financial institutions). Bearish positions for BSPM stock account 0.00%, no big difference from last month.

The following table compares ownership indicators for other stocks related to Biostar:

BSPM
Market cap$0.2 M
Total shares2.6 M
Float shares2.2 M
  - Institutional holdings (%)0.0%
  - Insider holdings (%)16.2%
Shares in short selling0.0%

Biostar summary

Friday, February 21st, 2020
Open$0.15
Close$0.08
Day range$0.08 - $0.15
Previous close$0.07
Session gain14.29%
Average true range$0.07
50d mov avg$0.13
100d mov avg$0.20
200d mov avg$0.83
Daily pattern
Weekly pattern lb06a

Biostar performance

To better understand Biostar Pharmaceuticals performance you must compare its gains with other related stocks in same sector or industry. We compared Biostar Pharmaceuticals against in the following table:
Stock3m6m12m
BSPMBiostar Pharmaceu...-33.33%-75.00%-86.67%

Biostar competitors

Unfortunately, we could not find any public company that could be defined as Biostar competitor. This doesn't mean Biostar does not have any competitor in the market, it's just we could not detected it.